Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 1998

Primary Completion Date

August 31, 2000

Study Completion Date

September 30, 2005

Conditions
Lung Cancer
Interventions
BIOLOGICAL

filgrastim

DRUG

carboplatin

DRUG

etoposide

DRUG

ifosfamide

PROCEDURE

in vitro-treated peripheral blood stem cell transplantation

Trial Locations (22)

13273

Institut J. Paoli and I. Calmettes, Marseille

21079

Centre de Lute Contre le Cancer,Georges-Francois Leclerc, Dijon

25030

CHR de Besancon - Hopital Saint-Jacques, Besançon

31052

Institut Claudius Regaud, Toulouse

33076

Institut Bergonie, Bordeaux

34295

Hopital Arnaud de Villeneuve, Montpellier

34298

Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle, Montpellier

38043

CHR de Grenoble - La Tronche, Grenoble

51056

Institut Jean Godinot, Reims

54511

CHRU de Nancy - Hopitaux de Brabois, Vandœuvre-lès-Nancy

67091

Hopitaux Universitaire de Strasbourg, Strasbourg

69373

Centre Leon Berard, Lyon

69394

Hopital Louis Pradel, Lyon

69495

Hopital Jules Courmont - Centre Hospitalier Lyon Sud, Pierre-Bénite

75248

Institut Curie - Section Medicale, Paris

75571

Hopital Saint Antoine, Paris

75970

Hopital Tenon, Paris

91640

CMC Bligny, Briis-sous-Forges

92210

Centre Rene Huguenin, Saint-Cloud

95300

Hopital Rene Dubos, Pontoise

06189

Centre Antoine Lacassagne, Nice

F-94805

Institut Gustave Roussy, Villejuif

All Listed Sponsors
lead

UNICANCER

OTHER

NCT00003860 - Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter